These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3057387)

  • 1. Methoctramine selectively blocks cardiac muscarinic M2 receptors in vivo.
    Wess J; Angeli P; Melchiorre C; Moser U; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):246-9. PubMed ID: 3057387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
    Angeli P; Cantalamessa F; Gulini U; Melchiorre C
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):304-7. PubMed ID: 8584046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective blockade in vivo of cardiac muscarinic M2 receptors by a polymethylene tetramine, BHC-9C.
    Wess J; Lambrecht G; Mutschler E; Melchiorre C; Angeli P
    Eur J Pharmacol; 1987 Oct; 142(3):475-8. PubMed ID: 3428357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat.
    Wess J; Lambrecht G; Moser U; Mutschler E
    Life Sci; 1984 Jul; 35(5):553-60. PubMed ID: 6379356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.
    Melchiorre C; Angeli P; Lambrecht G; Mutschler E; Picchio MT; Wess J
    Eur J Pharmacol; 1987 Dec; 144(2):117-24. PubMed ID: 3436364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of an M2-selective muscarinic antagonist in anaesthetized guinea-pigs.
    Howell RE; Kovalsky MP
    J Auton Pharmacol; 1995 Feb; 15(1):19-26. PubMed ID: 7744887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.
    Giachetti A; Micheletti R; Montagna E
    Life Sci; 1986 May; 38(18):1663-72. PubMed ID: 3754611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.
    Angeli P; Brasili L; Cantalamessa F; Marucci G; Wess J
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):625-9. PubMed ID: 2096296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methoctramine and hexahydrodifenidol antagonise two muscarinic responses on the rat superior cervical ganglion with opposite selectivity.
    Field JL; Newberry NR
    Neurosci Lett; 1989 May; 100(1-3):254-8. PubMed ID: 2761774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimuscarinic potency and functional selectivity of oxotremorine analogs at muscarinic receptor subtypes in the rat.
    Vargas HM; Ringdahl B
    Life Sci; 1990; 47(22):2065-73. PubMed ID: 1703260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro.
    Watson N; Barnes PJ; Maclagan J
    Br J Pharmacol; 1992 Jan; 105(1):107-12. PubMed ID: 1596672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time course of transmitter release in mouse motor nerve terminals is differentially affected by activation of muscarinic M1 or M2 receptors.
    Dudel J
    Eur J Neurosci; 2007 Oct; 26(8):2160-8. PubMed ID: 17953614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies.
    Michel AD; Whiting RL
    Eur J Pharmacol; 1988 Jan; 145(1):61-6. PubMed ID: 3127224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarine receptor types mediating autoinhibition of acetylcholine release and sphincter contraction in the guinea-pig iris.
    Bognar IT; Wesner MT; Fuder H
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):22-9. PubMed ID: 2179734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methoctramine, a cardioselective antagonist: muscarinic receptor mediating prostaglandin synthesis in isolated rabbit heart.
    Jaiswal N; Malik KU
    Eur J Pharmacol; 1991 Jan; 192(1):63-70. PubMed ID: 1904033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of methoctramine for muscarinic receptors in porcine cerebral arteries.
    Van Charldorp KJ; Davidesko D; Van Zwieten PA
    Eur J Pharmacol; 1988 May; 150(1-2):197-9. PubMed ID: 3402538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central muscarinic M2 cholinoceptors involved in cholinergic hypertension.
    Ozkutlu U; Onat F; Aslan AN; Oktay S
    Eur J Pharmacol; 1993 Dec; 250(3):349-54. PubMed ID: 8112394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methoctramine induces nonspecific airway hyperresponsiveness in vivo.
    Howell RE; Kovalsky MP; Laemont KD
    Eur J Pharmacol; 1994 Nov; 265(1-2):67-75. PubMed ID: 7883031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.